Author

P. H. Gann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. C. Saldana· 1 shared A. Das Gupta· 1 shared A. J. Smith· 1 shared A. T. Nelczyk· 1 shared B. Kirkpatrick· 1 shared C. Loitz· 1 shared C. P. Schane· 1 shared E. C. Fink· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. C. Saldana

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression

H. E. V. Gamage, S. H. Shahoei, S. T. Albright, Y. Wang, A. J. Smith, R. Farmer, E. C. Fink, E. Jacquin, E. Weisser, R. O. Bautista, M. A. Henn, C. P. Schane, A. T. Nelczyk, L. Ma, A. Das Gupta, , E. R. Nelson

This paper shows that NR0B2 in myeloid cells reduces Treg expansion and tumor growth by modulating the NLRP3 inflammasome, with small molecule agonists improving ICB efficacy in breast cancer.

bioRxiv · Aug 14, 2023 · PreprintCancer Biology

Prostate-derived circulating microRNAs add prognostic value to prostate cancer risk calculators

M. L. Zenner, B. Kirkpatrick, T. R. Leonardo, M. J. Schlicht, A. C. Saldana, C. Loitz, K. Valyi-Nagy, M. Maienschein-Cline, P. H. Gann, M. Abern, L. Nonn

The paper identifies prostate-derived microRNAs in serum and extracellular vesicles that improve prostate cancer risk prediction models.

bioRxiv · May 10, 2023Cancer Biology